Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: khrnyc who wrote (1890)	1/21/1998 10:53:00 AM
From: troy halle	Respond to of 7041

To: khrnyc who wrote (1890)	1/21/1998 11:24:00 AM
From: Tunica Albuginea	Read Replies (2) \| Respond to of 7041

To: khrnyc who wrote (1890)	1/21/1998 11:31:00 AM
From: Tokyo VD	Read Replies (1) \| Respond to of 7041

To: khrnyc who wrote (1890)	1/21/1998 8:12:00 PM
From: BDR	Read Replies (2) \| Respond to of 7041

<<You may read about this study in full in Zona's patent #5,565,466. >> I have read the patent. You haven't explained why the company has avoided the use of sub-lingual or buccal absorption as the means of administration and instead used "a pill" to describe their product which 99 out of a hundred people would assume to mean the normal oral route.